Immunohistochemistry staining assay was performed to further evaluate MEX3A expression in ovarian cancer and normal fallopian tube tissues based the Tissue Microarray (TMA) of high-grade serous ovarian cancer from our tissue bank. This evidence concerns the gene MEX3A and ovarian serous adenocarcinoma.